BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19399691)

  • 1. The Spt-Ada-Gcn5-acetyltransferase complex interaction motif of E2a is essential for a subset of transcriptional and oncogenic properties of E2a-Pbx1.
    Scheele JS; Kolanczyk M; Gantert M; Zemojtel T; Dorn A; Sykes DB; Möbest DC; Kamps MP; Räpple D
    Leuk Lymphoma; 2009 May; 50(5):816-28. PubMed ID: 19399691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification].
    Shestakova EA; Boutin M; Bourassa S; Bonneil E; Bijl JJ
    Mol Biol (Mosk); 2017; 51(3):490-501. PubMed ID: 28707666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
    Calvo KR; Knoepfler P; McGrath S; Kamps MP
    Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-binding by oncoprotein E2a-Pbx1 is important for blocking differentiation but dispensable for fibroblast transformation.
    Kamps MP; Wright DD; Lu Q
    Oncogene; 1996 Jan; 12(1):19-30. PubMed ID: 8552391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes.
    Lu Q; Knoepfler PS; Scheele J; Wright DD; Kamps MP
    Mol Cell Biol; 1995 Jul; 15(7):3786-95. PubMed ID: 7791786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The highest affinity DNA element bound by Pbx complexes in t(1;19) leukemic cells fails to mediate cooperative DNA-binding or cooperative transactivation by E2a-Pbx1 and class I Hox proteins - evidence for selective targetting of E2a-Pbx1 to a subset of Pbx-recognition elements.
    Knoepfler PS; Kamps MP
    Oncogene; 1997 May; 14(21):2521-31. PubMed ID: 9191052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts.
    Fu X; Kamps MP
    Mol Cell Biol; 1997 Mar; 17(3):1503-12. PubMed ID: 9032278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role for a single leucine residue in leukemia induction by E2A-PBX1.
    Bayly R; Murase T; Hyndman BD; Savage R; Nurmohamed S; Munro K; Casselman R; Smith SP; LeBrun DP
    Mol Cell Biol; 2006 Sep; 26(17):6442-52. PubMed ID: 16914730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation properties of the E2a-Pbx1 chimeric oncoprotein: fusion with E2a is essential, but the Pbx1 homeodomain is dispensable.
    Monica K; LeBrun DP; Dedera DA; Brown R; Cleary ML
    Mol Cell Biol; 1994 Dec; 14(12):8304-14. PubMed ID: 7969166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Hox cooperativity motif of the chimeric oncoprotein E2a-Pbx1 is necessary and sufficient for oncogenesis.
    Chang CP; de Vivo I; Cleary ML
    Mol Cell Biol; 1997 Jan; 17(1):81-8. PubMed ID: 8972188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1.
    Knoepfler PS; Calvo KR; Chen H; Antonarakis SE; Kamps MP
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14553-8. PubMed ID: 9405651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterodimerization of Hox proteins with Pbx1 and oncoprotein E2a-Pbx1 generates unique DNA-binding specifities at nucleotides predicted to contact the N-terminal arm of the Hox homeodomain--demonstration of Hox-dependent targeting of E2a-Pbx1 in vivo.
    Lu Q; Kamps MP
    Oncogene; 1997 Jan; 14(1):75-83. PubMed ID: 9010234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligomeric self-association contributes to E2A-PBX1-mediated oncogenesis.
    Lin CH; Wang Z; Duque-Afonso J; Wong SH; Demeter J; Loktev AV; Somervaille TCP; Jackson PK; Cleary ML
    Sci Rep; 2019 Mar; 9(1):4915. PubMed ID: 30894657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1.
    Fu X; McGrath S; Pasillas M; Nakazawa S; Kamps MP
    Oncogene; 1999 Sep; 18(35):4920-9. PubMed ID: 10490826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GCN5 acetylates and regulates the stability of the oncoprotein E2A-PBX1 in acute lymphoblastic leukemia.
    Holmlund T; Lindberg MJ; Grander D; Wallberg AE
    Leukemia; 2013 Mar; 27(3):578-85. PubMed ID: 23044487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional profiling during the early differentiation of granulocyte and monocyte progenitors controlled by conditional versions of the E2a-Pbx1 oncoprotein.
    Sykes DB; Scheele J; Pasillas M; Kamps MP
    Leuk Lymphoma; 2003 Jul; 44(7):1187-99. PubMed ID: 12916872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A conserved motif N-terminal to the DNA-binding domains of myogenic bHLH transcription factors mediates cooperative DNA binding with pbx-Meis1/Prep1.
    Knoepfler PS; Bergstrom DA; Uetsuki T; Dac-Korytko I; Sun YH; Wright WE; Tapscott SJ; Kamps MP
    Nucleic Acids Res; 1999 Sep; 27(18):3752-61. PubMed ID: 10471746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells.
    Bourette RP; Grasset MF; Mouchiroud G
    Oncogene; 2007 Jan; 26(2):234-47. PubMed ID: 16819510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of CBP/p300 recruitment in leukemia induction by E2A-PBX1.
    Denis CM; Chitayat S; Plevin MJ; Wang F; Thompson P; Liu S; Spencer HL; Ikura M; LeBrun DP; Smith SP
    Blood; 2012 Nov; 120(19):3968-77. PubMed ID: 22972988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials.
    Kamps MP; Look AT; Baltimore D
    Genes Dev; 1991 Mar; 5(3):358-68. PubMed ID: 1672117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.